Posts Tagged ‘cancer’
Inova Schar Cancer first in region to deliver Adaptive Online Radiation Therapy
Falls Church, VA – Inova Schar Cancer is proud to announce the rollout of Adaptive Online Radiotherapy – one of the most advanced forms of personalized radiation therapy available today. Inova is the first in the Greater Washington DC area to implement this new technology. Varian Ethos with Hypersight is a cutting-edge radiotherapy solution that…
Read More“Should Runners Be Worried About Colon Cancer?,” Runner’s World, September 19, 2025
While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening…
Read MoreWhy subspecialized cancer care matters
John Deeken, MD, is president of the Inova Schar Cancer and Medical Director for the Inova Schar Head and Neck Cancer Program. He is board-certified in medical oncology and specializes in head and neck cancers. When you or someone you love is diagnosed with cancer, one of the most important decisions you face is choosing…
Read More“Are Marathons and Extreme Running Linked to Colon Cancer?,” New York Times, August 19, 2025
Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured…
Read MoreInova Schar Cancer dosimetry team shines at AAMD International Planning Competition
Historic achievement showcases excellence in proton and photon therapy planning The medical dosimetry team at Inova Schar Cancer has achieved a historic milestone at the 2025 American Association of Medical Dosimetrists (AAMD) International Planning Competition, a globally recognized event showcasing cutting-edge treatment planning expertise. Competing against 194 submissions – 103 from the United States and…
Read MoreInova and the Virginia ACCESS Hub launch new study to evaluate multi-cancer detection tests
Inova, VCU, and Sentara enrolling participants in national study of blood tests designed to detect multiple cancer types Fairfax, VA – July 18, 2025 – Inova is now recruiting participants for the Vanguard Study, a national study of an innovative blood test that screens for several types of cancer. Researchers will evaluate whether these Multi-Cancer…
Read MoreInova becomes first in the mid-Atlantic region to offer GammaTile Therapy for brain tumors
Revolutionary technology for brain tumor treatment gives Brian new hope Brian Johnson has been through a lot since he was first diagnosed with kidney cancer in 2016. In addition to its effect on his kidney, the cancer eventually spread to his left lung and his brain. Again and again, with the support of his wife,…
Read MoreNicholas Hoo-Fatt recognized for pioneering detection of certain cancer cells
Inova Histology Program coordinator Nicholas Hoo-Fatt is helping inspire and nurture a new generation of histology professionals Inova Histology Program Coordinator and PhD candidate Nicholas Hoo-Fatt has been named one of the Top 55 Laboratory Professionals in the U.S. under the age of 55 by Medical Laboratory Observer. He also is the recipient of the…
Read MoreDebunking gynecology visit myths
Shawn Davis-Wilensky, MD is a board-certified obstetrician-gynecologist. She practices at Inova Saville Screening and Prevention Center. There are many myths that exist about women’s health. In order to make informed decisions about your care, it is important to be educated with the facts. Here are some myths debunked. Myth #1: The pill can increase cancer…
Read MoreInova Schar Cancer named top recruiter to innovative ER+ HER2- breast cancer clinical trial
Inova Schar Cancer is one of the top recruiting locations for the EMBER-4 clinical trial, a global study to evaluate a new treatment for ER+ HER2- breast cancer survivors EMBER-4 is a Phase 3 clinical trial comparing a new drug therapy, imlunestrant, to the standard drug therapy to treat women with ER+ HER2- breast cancer.…
Read More